Sun Pharma to acquire Organon in USD 11.75 billion deal
Sun Pharma→Organon
Apr 28, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Carasent has acquired InfoSolutions, a healthcare IT business in Sweden, for an Enterprise Value of SEK 115 million. Carasent acquisitions bring in InfoSolutions Sverige AB, which connects Electronic Health Record (EHR) systems with laboratories and radiology clinics across Sweden to order, track, and display diagnostic results. By integrating this EHR-to-lab and EHR-to-radiology workflow, Carasent strengthens its platform, increases switching costs for private providers, and expands its ecosystem reach across healthcare providers, labs, and imaging sites. The strategic acquisition is structured as a bolt-on acquisition, with 90% cash and 10% paid via repurchased Carasent shares, supporting healthcare M&A scale-up for a strategic buyer.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma→Organon
Apr 28, 2026
IMG Pharma→Matsumoto Pharmaceutical
Apr 27, 2026
TPG→Optum UK
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026